跳转至内容
Merck
CN

531278

Sigma-Aldrich

聚(异丁烯-alt-马来酸酐)

average Mw ~6,000, 12-200 mesh (85%)

别名:

马来酸共聚物, 马来酸类共聚物, 马来酸类聚合物

登录查看公司和协议定价

关于此项目

线性分子式:
(C4H2O3 · C4H8)X
CAS Number:
MDL编号:
UNSPSC代码:
12162002
NACRES:
NA.23
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

分子量

average Mw ~6,000

质量水平

粒径

12-200 mesh (85%)

固有粘度

0.45±0.05 dL/g, in DMF(30 °C)(lit.)

转变温度

Tg (DSC) 141 °C (onset)

溶解性

aqueous base: soluble

密度

1.3 g/mL at 25 °C (lit.)

SMILES字符串

O1C(=O)C=CC1=O.CC(=C)C

InChI

1S/C4H2O3.C4H8/c5-3-1-2-4(6)7-3;1-4(2)3/h1-2H;1H2,2-3H3

InChI key

RPOCFUQMSVZQLH-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

应用

以聚(异丁烯-丙烯酸-马来酸酐)为原料,用十二胺合成了两亲性聚合物。该聚合物是一种分散剂和表面活性剂。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Relaxation times of colloidal iron platinum in polymer matrixes.
Morales MP, et al.
Journal of Materials Chemistry, 19(35), 6381-6386 (2009)
Xueyan Mu et al.
Carbohydrate polymers, 90(4), 1582-1586 (2012-09-05)
In the present study, we report a facile method to fabricate polyelectrolyte based core-shell nanofibers with the assistance of the high gradient electric potential between the tip of capillary and the collector. The core-shell structure and the composition of each
P B Kernoff et al.
Blood, 63(1), 31-41 (1984-01-01)
Circulating antibodies to factor VIII (anti-VIII, "inhibitors") occurring in patients with hemophilia neutralize porcine factor VIII less readily than human factor VIII in vitro. Over an 18-mo period, 8 patients with anti-VIII were treated with 45 courses (297 infusions) of
Min Huang et al.
Journal of pharmaceutical sciences, 98(1), 268-280 (2008-04-22)
The therapeutic value of many growth factors is often hindered by the narrow therapeutic index and sustained concentrations required for efficacy. Controlled release approaches provide a valuable tool to achieve these goals; however, growth factor stability must be maintained. Repifermin
Abhimanyu Paraskar et al.
Nanotechnology, 22(26), 265101-265101 (2011-05-18)
The use of cisplatin, a first line chemotherapy for most cancers, is dose-limited due to nephrotoxicity. While this toxicity can be addressed through nanotechnology, previous attempts at engineering cisplatin nanoparticles have been limited by the impact on the potency of

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持